semaglutide colon cancer and Colorectal Risk: Research Explained GLP-1 drugs linked to major

In a groundbreaking investigation, Frejlachova et al

Combining these approaches warrants further research to fully understand long-term outcomes

Some report that a smaller dose allows them to: Maintain a healthy appetite while reducing food noise Support long-term metabolic health Avoid some of the gastrointestinal side effects that can occur with higher doses Take a more gradual, sustainable approach Again, there is limited research specifically evaluating long-term "microdosing" strategies, so decisions should always be individualized and made with a qualified healthcare professional

This review emphasizes the need for further research to confirm the efficacy of these treatments and guide clinical practice for Long COVID management